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Abstract 
TBIs produce a wide-range of neurological issues including, but not limited to, subdural 
hematoma, cognitive deficits, and in extreme cases, death. Although many mechanisms 
and consequences of TBI are well studied, there remains a gap in the understanding of the 
mechanisms by which repeated TBIs result in worse deficits than single injuries. Our lab 
has previously shown that repeated injuries occurring close in time impair the brain's 
metabolic recovery. In order to better understand the molecular mechanisms underlying 
the metabolic crisis associated with repeated TBI, we focused on central insulin signaling 
in mice injured once or twice, 24 hours apart. Insulin sensitivity assays were conducted 
by treating brain slices with insulin and measuring phosphorylation of Akt (protein kinase 
B) by Western Blot. Results showed that TBI induces brain insulin resistance by two 
days post-injury (DPI), which recovers by seven DPI in once-injured mice, but persisted 
until 28 DPI in mice that were injured twice.  Further, obese (thus whole-body insulin 
resistant) mice that underwent TBI showed longer lasting reductions in Akt signaling. 
Further investigation of the mechanism by which brain tissue becomes insulin resistant 
may aid in the understanding and treatment of patients having undergone a TBI.  
 
Introduction 
Traumatic brain injuries—described by the CDC as a bump, blow, or jolt to the 
head—are a significant problem among athletes, members of the armed forces, as well as 
all civilians (CDC 2014). Each year in the US, an estimated 1.4 million TBIs occur. 
However, it is believed that there far more injuries than included in this statistic due to 
the injuries being treated outside of a physician’s office or in military facilities in foreign 
countries (Langlois et al., 2006). A more severe problem arises when those who suffer an 
initial TBI suffer a second injury before the first resolves. In some cases, a second injury 
before the first has resolved has led to subdural hematoma, cognitive deficits, 
hemiparesis, and in extreme cases, death (Cantu & Gean, 2010). Moreover, following just 
one injury, the brain is characterized by hyperglycolysis, in which the energy demands 
are increased in order to meet the demands from the injury (Bergsneider et al., 1997; 
Oddo et al., 2008). And following a period of hyperglycolysis, the brain experiences an 
even longer period of hypoglycolysis (Prins et al., 2013). These metabolic dysfunctions 
are associated with an increase in vulnerability, such that even a mild second injury may 
result in a worse outcome (Prins et al., 2010, 2013; Fujita et al., 2012; Weil et al., 2014). 
Possible mechanisms for the metabolic abnormalities following injury include altered 
GLUT3 transporter expression (Hamlin et al., 2001) and oxidative stress (Kammaksh et 
al., 2014). However, it may be possible that a mediator of brain glucose utilization post-
injury is insulin. Although insulin was thought to have no effect on glucose control in the 
brain (Oddo et al., 2008), its local synthesis and transporter density in the blood brain 
barrier suggest that it may have an important effect (Banks, 2004; Ghasemi et al., 2013).  
Downstream of the insulin receptor are insulin receptor substrate proteins that 
couple the receptor to the phosphoinostitide 3-kinase (PI3K) cascade (Gual et al., 2005). 
Further downstream after PI3K has been activated, protein kinase B (Akt) is 
phosphorylated (Lima et al., 2002). And although the effect of insulin on glucose 
utilization in the brain is not completely understood, it has been used as a therapeutic 
agent due to the increasing evidence for brain insulin-dependent glucose utilization 
(Gerozissis, 2008). Additionally, brain insulin resistance has been linked to 
neurodegenerative diseases such as Parkinson’s and Alzheimer’s (Cardosa et al., 2009). 
Perhaps most important for insulin’s use as a therapeutic agent is its role in neurogenesis 
and reduction of neuroinflammation (Bateman & McNeill, 2006; Adzovic et al., 2015). 
Further, obesity, and perhaps the insulin resistance seen with type 2 diabetes as a result of 
obesity, has been shown to increase mortality and complications after sustaining blunt 
trauma (Brown et al., 2005). But since little is known about the relationship of TBI and 
brain insulin signaling, there remains a critical need to understand the biochemical 
mechanism behind the metabolic abnormalities to help improve outcome for future 
patients.  
 
Materials and Methods 
Animals 
C57/Bl6 mice were obtained from Charles River and bred in our colony. Animals were 
maintained in a temperature and humidity controlled vivarium on a 14:10 light/dark 
cycle. Mice were given ad-libitum access to food (Teklad #8640, Harlan unless otherwise 
specified) and water. The study was conducted in accordance with The Ohio State 
University guidelines for the care and use of animals under protocols approved by the 
Institutional Animal Care and Use Committee. 
 
Traumatic Brain Injury 
At 6 weeks of age, male mice were subjected to either a mild TBI or sham procedure. 
Mice were anesthetized and their scalps shaved. They were then secured into a 
stereotaxic frame and skull surfaces were exposed. The impactor tip (round 3mm 
diameter, Leica) was placed on the skull (-2 mm AP, -2 mm ML relative to bregma), 
retracted, and driven into the skull at 3 m/s to a depth of 1.4 mm. Anesthesia was turned 
off immediately prior to impact in order to measure the amount of time to regain 
consciousness. Sham procedures were identical except after the impactor was placed 
gently on the skull, it was then retracted. The return to consciousness—or time to awake 
(TTA)—was measured by placing each mouse on its back after suturing the scalp post-
injury, and watching for the mouse to bring itself onto all four paws. Mice undergoing 
TBI had their skin closed immediately after injury, while still unconscious with sterile 
surgical clips, and sham mice had their skin clipped just before removal from anesthesia. 
Each mouse underwent two procedures 24 h apart—a manipulation that produced three 
groups: sham/sham, TBI/sham, or TBI/TBI. All animals were treated with 0.1 mg/kg 
subcutaneous buprenorphine and monitored for pain/discomfort throughout the study. 
Additional buprenorphine was available at 12 h intervals for these mice.  
 
Diet Induced Obesity 
Diet-induced obesity was achieved using a maternal obesity model (Samuelsson et al., 
2008), which developmentally programs hyperphagia. Additionally, the maternal diet-
induced obesity model exposes pups to neonatal hyperinsulinemia. At 4 weeks of age, 
female mice were given either a low-fat standard chow diet (LFD) (10% of calories from 
fat) or a high-fat diet (HFD) (60% of calories from fat) (D12492, Research Diets). Mice 
were given ad-libitum access. Females were then paired with a breeder male at 6 weeks 
of age. Pregnant mothers maintained their respective diets through gestation and 
lactation. At 3 weeks of age, pups were weaned onto the same diets as their mothers.   
 Ex-vivo insulin stimulation 
Mice were decapitated and fresh brains were immediately collected. The frontal lobe of 
the left hemisphere (injury side) was sliced at 0.4 mm intervals using a McIlwain tissue 
chopper. Slices were then maintained in oxygenated artificial cerebrospinal fluid (aCSF) 
[containing 127 nM NaCl, 24 nM NaHCO3, 1.2 nM NaH2PO4, 2.5 nM KCl, 1nM MgCl, 
25 nM glucose, 2 nM CaCl2] at 37 °C for 20-30 min. Half of the slices from each left 
hemisphere were then incubated with 10 nM insulin (Sigma, St. Louis, MO, USA), and 
the other half with aCSF for 10 min at 37 °C. Following incubation, tissues were washed 
in ice-cold aCSF and lysed in radio-immunoprecipitation assay buffer containing 
phosphatase and protease inhibitors (Invitrogen). Total protein concentration was 
measured using a bicinchoninic acid protein assay (BCA; Bio-Rad).  
 
Western Blotting 
Protein analysis was performed by subjecting protein lysates to SDS-PAGE. 40 µg of 
protein was electrophoresed into a precast gel (Bio-Rad, 4-15%), transblotted onto a 
polyvinylidene difluoride membrane, and then blocked with 5% milk in tris-buffered 
saline (TBS). Following, membranes were incubated overnight at 4°C in TBS with 0.01% 
tween and rabbit anti-phosphorylated Akt (1:3,000 Ser 473 Cell Signaling) and GAPDH 
(1:2,000 Cell Signaling) antibodies, then goat anti-rabbit IgG HRP-conjugated secondary 
antibody (1:2,000 R & D) and visualized with enhanced chemiluminescent substrate 
(Invitrogen). Membranes were stripped (GM Biosciences) following this analysis, and 
reblotted with anti-rabbit pan Akt (1:2,000), Cell Signaling). The level of protein 
expression was determined by densitometry calculation via Image J (Abràmoff et al., 
2004) and reported as pAkt(Ser473):pan Akt. 
 
Histology Analysis 
Phosphorylated Akt staining photomicrographs were captured at 10 x magnification 
throughout the sensorimotor cortex spanning bregma 0.02 to -1.34 mm (Paxinos & 
Franklin, 2004). Cell numbers were quantified in a 0.04 mm2 area using ImageJ software 
and analyzed by cell number/mm2. Data are collected from both hemispheres, but no 
significant differences were found. Thus, the data are reported as an average of the two.  
 
Silver Staining 
Axonal degeneration was assessed by silver staining using a NeuroSilver kit (FD 
Neurotechnologies) according to the manufacturer’s instructions. Brain sections spanning 
the entire forebrain (roughly 12 section/brain) were analyzed at 10X magnification by a 
blinded observer. The level of silver staining was assessed on a four-point scale (0, no 
staining; 3, presence of silver staining in multiple white matter tracts throughout the 
forebrain). 
 
Statistical Analysis 
Statistical analysis was performed using SPSS Version 23 (IBM Corp., Armonk, NY, 
USA). Insulin stimulation data for time course experiments were analyzed via ANOVA 
(injury x insulin dose). Diet experiments with insulin stimulation data were also analyzed 
via ANOVA (injury x insulin dose x diet). Qualitative axonal degeneration data were 
analyzed via the Mann-Whitney U-test.  
 
Experimental Protocol 
Experiment 1: 
Traumatic brain injury effects on brain insulin resistance 
Male mice underwent one TBI followed by a sham procedure (24 h apart), two TBIs (24 
h apart), or two sham procedures (24 h apart), and brain tissue was collected for ex-vivo 
insulin stimulation on two (sham, n = 6, one injury, n = 7; two injuries, n = 7), seven (one 
injury, n = 7; two injuries, n = 6), 14 (one injury, n = 5; two injuries, n = 6), or 28 (two 
injuries, n = 8) days post-injury (Fig. 1A).  
 
Experiment 2: 
Diet-induced obesity effects on traumatic brain injury 
Male mice that were weaned onto their mother’s diet underwent two TBIs (24 h apart) or 
two sham procedures (24 h apart). Thus, we were given four groups: LFD/sham, 
LFD/TBI, HFD/sham, HFD/TBI. Brain tissue was collected for ex-vivo insulin 
stimulation two days post-injury (n = 10/group, total n = 40).  
 
Results 
Traumatic Brain Injury Induces Long-Lasting Insulin Resistance 
To determine brain insulin receptor sensitivity as a result of TBI, brains from sham, once, 
and twice injured mice were treated ex-vivo with 0 or 10 nM insulin. Phosphorylation of 
Akt at serine 473 relative to total Akt was used as an indicator of insulin receptor 
activation (Fig. 2A). Western blot analysis showed a significant increase in Akt 
phosphorylation in sham brains when treated with insulin (F2, 14 = 4.436, P = 0.036), but 
no insulin-dependent increase in Akt phosphorylation in injured mice at two days post-
injury (DPI) (Fig. 2B). At seven DPI brain tissue from mice having undergone one injury 
recovered insulin sensitivity (F1,8 = 8.377, P = 0.23), which persisted at 14 DPI (F1,5 = 
9.110, P = 0.039). However, mice injured twice remained insulin resistant at both 7 and 
14 DPI (Figs. 2C,D). Because insulin sensitivity persisted in the once-injured animals at 
14 DPI (Fig 2D), only the twice-injured animals were repeated until 28 DPI. At this time 
point, insulin sensitivity assessed through the ratio of phosphorylated Akt:pan Akt was 
significantly increased post insulin treatment (F1,11 = 6.294, P = 0.0310; Fig. 2E).  
 
High-fat diet has no effect on severity of injury 
By using a maternal diet-induced obesity model, we were able to determine whether or 
not pre-existing, whole body insulin resistance exacerbates TBI-induced insulin receptor 
insensitivity. Pregnant females and their offspring were fed either a LFD or HFD, and at 
six weeks of age, the offspring underwent either a sham surgery or TBI. Mice fed the 
HFD had a significantly increased body mass (F1,31 = 67.402, P < 0.0001), but this did not 
have a noticeable effect on brain damage following TBI, as both HFD and LFD TBI 
animals showed no significant difference in TTA following injury (Fig. 3). Additionally, 
axonal degeneration assessed through silver staining showed that TBI increased axon 
damage relative to sham (U = 1.5, P < 0.001), but did so to a similar extent in both HFD 
and LFD groups (Fig. 3). Thus, we can conclude that the effect of diet on insulin 
sensitivity appeared to be independent of severity of injury.  
 
High-fat diet acutely increases traumatic brain injury-induced Akt phosphorylation 
Ex-vivo insulin stimulation on HFD and LFD mice showed that brain tissue from LFD 
sham animals responded to insulin through a significant increase in phosphorylated Akt 
expression (F1,11 = 6.101, P = 0.033), whereas brain tissue from the HFD sham mice did 
not increase expression of phosphorylated Akt post-insulin stimulation. Further, both 
HFD and LFD TBI animals experienced insulin resistance following injury. However, 
although insulin-dependent Akt phosphorylation did not increase relative to control after 
injury, phosphorylated Akt expression was significantly greater in HFD-TBI mice when 
compared to HFD-sham mice (F1,28 = 5.003, P = 0.033). Thus, the data suggest that TBI 
influenced an increase in insulin-independent Akt phosphorylation in HFD mice. 
Additionally, the insulin-independent increase in expression of phosphorylated Akt was 
significantly higher in HFD mice than LFD mice following TBI (F1,33 = 4.806, P = 
0.036). When taken together, the data suggest that at two DPI, HFD increased Akt 
phosphorylation post-TBI (Fig. 4A and B). 
 
Discussion 
Our experiment design was based on two main findings: following TBI, insulin resistance 
has been shown to increase mortality (Ley et al., 2011), and the brain has a period of 
disrupted metabolism (Prins et al., 2013, Weil et al., 2014). The results showed that in 
mice, insulin resistance following one mild TBI persists until 7 DPI, but persists until 28 
DPI following two injuries.  
It may be possible that the reduced phosphorylation of Akt plays a role in the 
exacerbated outcomes following TBI. Akt has been shown to have a neuroprotective 
effect (Zhao et al., 2006), and also when inactivated can exacerbate damage from injury 
(Miyawaki et al., 2009). Our model shows that insulin was unable to activate 
/phosphorylate Akt. Although whether or not insulin directly influences brain glucose 
metabolism remains under debate (Oddo et al., 2008), increasing evidence shows a 
connection to insulin-dependent glucose homeostasis (Gerozissis, 2008). Further, insulin 
activity has been shown to stimulate the uptake and utilization of glucose following 
oxidative stress (Duarte, et al., 2006), which is a component of repeated TBI 
(Kammaksh, et al., 2016). We are unaware of any other report on the changes seen in 
insulin-dependent Akt phosphorylation following TBI. Our data make sense due to the 
many other studies that have shown vulnerability of the brain after receiving a TBI. And 
further, it may be possible that the exacerbated damage seen following repeated TBIs 
occurring close in time may be impacted by brain insulin resistance.  
In order to further explore the effect of insulin resistance and TBI, we used a diet-
induced obesity model—hoping to create brain insulin resistance. Mothers of mice and 
their offspring were fed either a HFD or LFD and subjected to either a sham procedure or 
injury. Consistent with a previous report (Arnold et al., 2014), the data showed that the 
diet-induced obesity induced insulin resistance. We were then able to examine the effects 
of prior whole-body insulin resistance on the outcome of injury and recovery following 
TBI. Results showed that although the phosphorylation of Akt was significantly higher in 
HFD-TBI mice compared to the LFD-TBI group. Further, the ratios of phosphorylated 
Akt:pan Akt were higher in insulin-stimulated (10 nM insulin in artificial cerebrospinal 
fluid) and control (artificial cerebrospinal fluid only) HFD mice following TBI, 
suggesting an insulin-independent increase in Akt phosphorylation. Interestingly, 
exogenous insulin did not increase the phosphorylation of Akt. Additionally, Akt 
phosphorylation can happen through various signaling pathways, thus changes in the 
amount of phosphorylated Akt may have been a result of other biochemical processes.  
Although we discovered insulin resistance in our animal models, the cause of the 
mechanism of insulin resistance remains unknown. Inflammation has been shown to be 
associated with insulin resistance (Dandona et al., 2004), obesity (Hotamisligil, 2006), 
and TBI (Werner and Engelhard, 2007). Thus, the role of inflammation may have 
contributed to, or possibly be a mechanism for the associated insulin resistance that 
resulted. Further investigation of the post-TBI mechanism by which inflammatory 
molecules may affect neuronal metabolism and recovery may allow for better treatment 
to decrease the resulting deficits.   
 
 
 
 
 
 
 
 
Figures 
	
Figure	1:	Experimental	timeline.	Experiment	1:	Insulin	resistance	time	course.	A	time	course	of	insulin	
receptor	sensitivity	was	assessed	in	groups	of	sham,	one	injury,	and	two	injuries	on	days	2,	7,	14,	and	28	
post	injury.	Experiment	2:	Diet-induced	obesity.	Mice	raised	on	a	maternal	obesity	model	(HFD)	or	
standard	diet	(LFD)	underwent	sham	or	TBI	procedures	24	h	apart.	Their	insulin	sensitivity	was	tested	
two	DPI	and	tissue	was	stained	following	sacrifice	16	DPI.	 
 
 
 
Figure	2:	TBI-induced	brain	insulin	resistance.	Western	blots	of	frontal	brain	tissue	from	sham	
(sham/sham),	1	injury	(TBI/sham),	and	2	injuries	(TBI/TBI)	mice	with	(+)	or	without	(-)	insulin	
stimulation.	Tissue	was	collected	2,	7,	14,	or	28	days	post	injury	(DPI).	Analysis	shows	that	insulin	
stimulation	leads	to	activation	of	Akt	in	sham	injured,	two	but	not	in	injured	mice	two	DPI.	Mice	
that	were	injured	a	single	time	recover	insulin	sensitivity	by	7	DPI,	which	continues	14	DPI.		Mice	
injured	twice	remained	insulin	resistant	through	14	DPI,	and	insulin	sensitivity	was	normalized	by	
28	DPI. 	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure	3:	High	fat	diet	effects	on	insulin	sensitivity	are	independent	of	injury	severity.	Axonal	
degeneration	was	assessed	by	silver	staining	mice	brain	tissue.	Silver	score	analysis	(0	=	no	
staining,	3	=	presence	of	silver	staining	in	multiple	white	matter	tracts	throughout	the	forebrain)	
shows	that	TBI	significantly	increased	axon	damage	relative	to	sham,	but	was	not	affected	by	diet.	
Further,	injury	also	shows	a	significant	difference	in	relation	to	sham	time	to	awake	(TTA),	but	is	
independent	of	diet.	
Figure	4:	High	fat	diet	induces	central	insulin	resistance	and,	with	TBI,	increased	Akt	
phosphorylation.	Western	blots	of	frontal	brain	tissue	from	low-fat	diet	(LFD)	and	high-fat	diet	
(HFD)	sham	or	TBI	mice	(+)	or	without	(-)	insulin	stimulation.	Analysis	shows	that	brain	tissue	
from	sham	animals	fed	a	LFD	responds	with	an	increase	in	pAkt	expression,	and	tissue	from	HFD-
fed	animals	does	not.	Both	LFD-	and	HFD-fed	mice	experience	brain	insulin	resistance	following	a	
TBI.	Brain	tissue	from	HFD-TBI	mice	exhibits	an	increase	in	Akt	phosphorylation	compared	to	
HFD-sham	mice	brain	tissue,	suggesting	that	TBI	increases	insulin-independent	Akt	
phosphorylation	in	HFD-fed	mice.	 
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